Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi
Maria Assunta Rocca

Showing results (1041-1050 of 1,159) with videos related to

Pageof 116
Sort By:
Nature Reviews. Neurology|September 3, 2024
The influence of MOGAD on diagnosis of multiple sclerosis using MRIRuth Geraldes, Georgina Arrambide, Brenda Banwell, et al.
Journal of Neurology|December 22, 2023
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS RegistryPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Annals of Clinical and Translational Neurology|January 25, 2025
Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophyErmelinda De Meo, Emilio Portaccio, Rosa Cortese, et al.
Journal of Neurology|September 12, 2024
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
European Stroke Journal|February 17, 2025
Cerebral thrombus analysis as a useful diagnostic tool for infective endocarditis in ischemic stroke patientsAurora Semerano, Beatrice Dell'Acqua, Angela Genchi, et al.
Journal of Neuroimmunology|August 14, 2023
Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumabAlessandra Sottini, Virginia Quaresima, Mosè Barbaro, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 14, 2016
An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's diseaseLidia Sarro, Nirubol Tosakulwong, Christopher G Schwarz, et al.
Journal of Neurology|August 23, 2024
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosisMarta Simone, Giuseppe Lucisano, Tommaso Guerra, et al.
European Journal of Neurology|September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosisIrene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
The Lancet. Neurology|September 5, 2009
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre studyPaul O'Connor, Massimo Filippi, Barry Arnason, et al.
Pageof 116

Showing results (1041-1050 of 1,159) with videos related to

Sort By:
Pageof 116
Nature Reviews. Neurology|September 3, 2024
The influence of MOGAD on diagnosis of multiple sclerosis using MRIRuth Geraldes, Georgina Arrambide, Brenda Banwell, et al.
Journal of Neurology|December 22, 2023
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS RegistryPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Annals of Clinical and Translational Neurology|January 25, 2025
Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophyErmelinda De Meo, Emilio Portaccio, Rosa Cortese, et al.
Journal of Neurology|September 12, 2024
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
European Stroke Journal|February 17, 2025
Cerebral thrombus analysis as a useful diagnostic tool for infective endocarditis in ischemic stroke patientsAurora Semerano, Beatrice Dell'Acqua, Angela Genchi, et al.
Journal of Neuroimmunology|August 14, 2023
Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumabAlessandra Sottini, Virginia Quaresima, Mosè Barbaro, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 14, 2016
An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's diseaseLidia Sarro, Nirubol Tosakulwong, Christopher G Schwarz, et al.
Journal of Neurology|August 23, 2024
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosisMarta Simone, Giuseppe Lucisano, Tommaso Guerra, et al.
European Journal of Neurology|September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosisIrene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
The Lancet. Neurology|September 5, 2009
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre studyPaul O'Connor, Massimo Filippi, Barry Arnason, et al.
Pageof 116